Company: LRHC
Filing Date: 2025-05-29
Form Type: 10-Q
Source: 0001213900-25-048370
Chunk: 35

Company: La Rosa Holdings Corp.
Filing Date: 2025-05-29
Form: 10-Q
Item: Item 1
Chunk 35
---
 Balance — March 31, 2025 
     714,071  
    $1.81 

On February 1, 2025, a Restricted Stock Unit (“RSU”) covering
4,000 shares granted to the Company’s Chief Technology Officer (“CTO”) vested. The Company withheld 1,187 shares to
cover payroll tax withholding and issued 2,813 shares to the executive. The Company also granted a new RSU to the CTO on February 1, 2025,
which will vest on the first anniversary of the grant.

During the three-month period ending March 31, 2025, the Company issued
644,117 RSU’s to agents as part of our agent incentive plan and 2,000 RSU’s to our CTO as part of his employment agreement.

For the three-month periods ending March 31, 2025
and 2024, the Company recorded $21,973 and $2,871, respectively, of share-based compensation expense related to the RSUs. The
Company did not realize any tax benefits associated with share-based compensation for the three-month periods ended March 31, 2025 and
2024, as the Company recorded a valuation allowance on all deferred tax assets.

Note 9 — Earnings Per Share

Basic loss per share of common stock attributable
to common stockholders is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of
common stock outstanding during the period. Diluted loss per share of common stock attributable to common stockholders is computed by
giving effect to all potential shares of common stock, including those related to the Company’s outstanding warrants, options and
RSUs, to the extent dilutive. For all periods presented, these potential shares were excluded from the calculation of diluted loss per
share because their inclusion would be anti-dilutive. As a result, diluted loss per common share is the same as basic loss per common
share for all periods presented.

20

La Rosa Holdings Corp. and Subsidiaries
Notes to the Unaudited Condensed Consolidated Financial Statements

The following table sets forth common stock equivalents
that have been excluded from the computation of dilutive weighted average shares outstanding as their inclusion would have been antidilutive:

    As of 

    March 31, 

    2025  
    2024 
  
    Warrants 
     2,774,879